2K1C-induced Hypertension Model in SD Rat

Bioanalytical Services
Phenotyping Services
Oncology PlatformMetabolism PlatformEfficacy and Pathology Platform
Anti-Tumor Drug Efficacy Evaluation
Humanized Immune Checkpoint Mouse Models and Efficacy Services
Non-GLP Toxicity Assessment Services
Metabolic Disease Efficacy Evaluation
Obesity Models and Efficacy ServicesType II Diabetes Models and Efficacy ServiceType I Diabetes Models and Efficacy ServicesAndrogenetic Alopecia (AGA) Models and Efficacy ServicesMASH Models and Efficacy ServicesChronic Liver Fibrosis Models and Efficacy ServicesAcute Liver Injury Models and Efficacy ServicesCholestasis Models and Efficacy ServicesAlcohol-related Liver Disease (ALD) Models and Efficacy ServicesGout/Hyperuricemia Models and Efficacy Services
Autoimmune Disease Efficacy Evaluation
Autoimmune Nephropathy Models and Efficacy ServicesAsthma Models and Efficacy ServicesSystemic Lupus Erythematosus (SLE) Models and Efficacy ServicesSjögren's Syndrome Models and Efficacy ServicesNeuroimmune Diseases Models and Efficacy ServicesAutoimmune Dermatoses Models and Efficacy ServicesInflammatory Bowel Disease (IBD) Models and Efficacy ServicesRheumatoid Arthritis (RA) Models and Efficacy ServicesImmune Reconstitution Autoimmune Disease Models and Efficacy Services
Neurological Disease Efficacy Evaluation
In Vitro TestingBehavioral AnalysisIn Vivo Drug Efficacy EvaluationIn Vivo Biochemical ExaminingParkinson’s Disease Rat Model
Cardiovascular Diseases Efficacy Evaluation
Heart Failure Models and Efficacy ServicesHypertension Models and Efficacy ServicesAtherosclerosis Models and Efficacy ServicesAdvanced Cardiovascular and Metabolic Complication Models and Efficacy ServicesHyperlipidemia Models and Efficacy ServicesHypertropic Cardiomyopathy Models and Efficacy ServicesStroke Models and Efficacy ServicesThrombosis Models and Efficacy Services
Cell Therapy & Gene Therapy Efficacy Evaluation
Disease Rat Models
5/6 Nephrectomy-induced Rat CKD ModelCCL4-induced Chronic Liver Fibrosis Models in SD RatSTZ-induced Type I Diabetes Model in SD RatOVX-induced Rat Osteoporosis ModelMCAO-induced CIS Model in SD Rat2K1C-induced Hypertension Model in SD Rat

Hypertension (HTN) is a chronic medical condition characterized by persistently elevated systemic arterial blood pressure (BP).


2K1C-induced hypertension model in SD rat


The two-kidney, one-clip (2K1C) model is a widely used experimental approach to induce renovascular hypertension in rodents by surgically placing a constrictive clip on one renal artery while leaving the contralateral kidney intact. This results in chronic activation of the renin-angiotensin system (RAS), leading to sustained hypertension and end-organ damage.

 

图片1.png 

Fig.1 Overview of pharmacodynamic evaluation on 2K1C-induced rat hypertension model

 

 图片2.png

Fig.2 Body weight of 2K1C-induced rat hypertension model


There was no significant difference in body weight between 2K1C-induced hypertensive rats and sham operation rats. Data were presented by mean ± SEM, n=5-10. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001

 

图片3.png

Fig.3 Blood pressure and serum CREA, UREA, LDH and CK of 2K1C-induced rat hypertension model


SBP in 2K1C-induced hypertensive rats was significantly higher than that in sham operation rats(Fig. 3A,D). Serum CREA of both male and female hypertensive rats induced by 2k1c was significantly higher than that of sham operation rats(Fig. 3B,E), serum LDH of male model rats was significantly increased, while serum LDH of female rats was not significantly different from that of sham operation group(Fig. 3C,F). Data were presented by mean ± SEM, n=5-10. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001

TALK WITH OUR EXPERTS

GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.